This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Urbanek, M. Articles by Dunaif, A. Search for Related Content PubMed PubMed Citation Articles by Urbanek, M. Articles by Dunaif, A. Related Collections Diabetes and Insulin Female Endocrinology Male Endocrinology Metabolism

Identification of a Polycystic Ovary Syndrome Susceptibility Variant in Fibrillin-3 and Association with a Metabolic Phenotype

Division of Endocrinology, Metabolism, and Molecular Medicine (M.U., S.S., A.D.), Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611; and Department of Obstetrics and Gynecology (R.S.L.), Pennsylvania State University College of Medicine, Hershey, Pennsylvania 17033

Address all correspondence and requests for reprints to: Margrit Urbanek, Division of Endocrinology, Metabolism, and Molecular Medicine, 303 East Chicago Avenue, Tarry 15-717, Chicago, Illinois 60611. E-mail: m-urbanek{at}northwestern.edu.

Context: Polycystic ovary syndrome (PCOS), the most common reproductive endocrine disorder of premenopausal women, is also associated with metabolic abnormalities including insulin resistance and an increased risk for diabetes mellitus. We previously mapped a PCOS susceptibility locus to chromosome 19p13.2 near the dinucleotide repeat marker D19S884.

Objective: Our objective is to localize the chromosome 19p13.2 PCOS susceptibility locus and determine its impact on metabolic features of PCOS.

Design: Resequencing and family-based association testing were used to examine the effect of sequence variation within 100 kb of D19S884 on the reproductive and metabolic phenotypes of PCOS.

Setting: The study was conducted in an academic medical center.

Subjects: Genetic analyses were performed on DNA obtained from1723 individuals in 412 families with 412 index cases and 43 affected sisters of predominantly European origin (>94%). Genotype-phenotype associations were assessed in 601 women with PCOS and 168 brothers of affected women.

Results: D19S884 allele 8 (A8) within intron 55 of the fibrillin-3 (FBN3) gene showed the strongest evidence for association with PCOS of 53 variants tested (P_corrected = 0.0037). A8 was also associated with higher levels of fasting insulin and homeostasis model assessment for insulin resistance in women with PCOS and higher fasting levels of proinsulin and proinsulin/insulin ratio in brothers.

Conclusions: These findings strongly suggest that A8 of D19S884 is the chromosome 19p13.2 PCOS susceptibility locus. The association of D19S884 with markers of insulin resistance and pancreatic ß-cell dysfunction suggests that the same variant contributes to the reproductive and metabolic abnormalities of PCOS in affected women and their brothers.

This article has been cited by other articles:

				M. J. Prodoehl, N. Hatzirodos, H. F. Irving-Rodgers, Z. Z. Zhao, J. N. Painter, T. E. Hickey, M. A. Gibson, W. E. Rainey, B. R. Carr, H. D. Mason, et al. Genetic and gene expression analyses of the polycystic ovary syndrome candidate gene fibrillin-3 and other fibrillin family members in human ovaries Mol. Hum. Reprod., December 1, 2009; 15(12): 829 - 841. [Abstract] [Full Text] [PDF]

				A. D. Coviello, S. Sam, R. S. Legro, and A. Dunaif High Prevalence of Metabolic Syndrome in First-Degree Male Relatives of Women with Polycystic Ovary Syndrome Is Related to High Rates of Obesity J. Clin. Endocrinol. Metab., November 1, 2009; 94(11): 4361 - 4366. [Abstract] [Full Text] [PDF]

				M. Urbanek, G. Nampiaparampil, J. D'Souza, E. Sefton, C. Ackerman, R. S. Legro, and A. Dunaif The Role of Genetic Variation in the Lamin A/C Gene in the Etiology of Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., July 1, 2009; 94(7): 2665 - 2669. [Abstract] [Full Text] [PDF]

				M.O. Goodarzi, J.F. Maher, J. Cui, X. Guo, K.D. Taylor, and R. Azziz FEM1A and FEM1B: novel candidate genes for polycystic ovary syndrome Hum. Reprod., December 1, 2008; 23(12): 2842 - 2849. [Abstract] [Full Text] [PDF]

				M. Demissie, M. Lazic, E. M. Foecking, F. Aird, A. Dunaif, and J. E. Levine Transient prenatal androgen exposure produces metabolic syndrome in adult female rats Am J Physiol Endocrinol Metab, August 1, 2008; 295(2): E262 - E268. [Abstract] [Full Text] [PDF]

				S. Sam, A. D. Coviello, Y.-A. Sung, R. S. Legro, and A. Dunaif Metabolic Phenotype in the Brothers of Women with Polycystic Ovary Syndrome Diabetes Care, June 1, 2008; 31(6): 1237 - 1241. [Abstract] [Full Text] [PDF]